Israeli Covid drug also aids cancer immunotherapy patients

Israel 21C 18.05.2022

Bonus BioGroup’s MesenCure drug shown to lower the inflammatory overreaction in cancer patients that can cause multisystem failure.

Israeli biotechnology company Bonus BioGroup announced that its Covid drug, MesenCure, can also reduce life-threatening inflammatory overreaction in cancer patients treated with immunotherapy.

Did you find this article interesting?

Comments

Joy Moss-Rendell 13:53 18.05.2022 2 years ago

If this is fact it's terrific.

Phillip Avalos 03:49 18.05.2022 2 years ago

That’s very nice!!✡️✡️🇮🇱🇮🇱

To leave a comment, please log in

DISCOVER MORE

"Iron Swords" - War in Gaza Benjamin Netanyahu Hamas The Iran Threat Biden Administration The Leftist-Islamist Alliance Hezbollah Israeli Technology Palestine = Hamas = ISIS Israeli_Nature 10/7 Hamas Massacres Biblical Archaeology Jihadi Infiltration into the West Heroes of Israel The Bible Muslim Persecution of Jews

Subscribe to our Newsletter